Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
ZNF750 Expression Is a Potential Prognostic Biomarker in Esophageal Squamous Cell Carcinoma.
Otsuka R, Akutsu Y, Sakata H, Hanari N, Murakami K, Kano M, Toyozumi T, Takahashi M, Matsumoto Y, Sekino N, Yokoyama M, Okada K, Shiraishi T, Komatsu A, Iida K, Matsubara H. Otsuka R, et al. Among authors: toyozumi t. Oncology. 2018;94(3):142-148. doi: 10.1159/000484932. Epub 2017 Dec 8. Oncology. 2018. PMID: 29216641 Free PMC article.
Antitumor effects of metformin are a result of inhibiting nuclear factor kappa B nuclear translocation in esophageal squamous cell carcinoma.
Sekino N, Kano M, Matsumoto Y, Sakata H, Akutsu Y, Hanari N, Murakami K, Toyozumi T, Takahashi M, Otsuka R, Yokoyama M, Shiraishi T, Okada K, Hoshino I, Iida K, Akimoto AK, Matsubara H. Sekino N, et al. Among authors: toyozumi t. Cancer Sci. 2018 Apr;109(4):1066-1074. doi: 10.1111/cas.13523. Epub 2018 Feb 26. Cancer Sci. 2018. PMID: 29396886 Free PMC article.
SIRT1 Expression Is a Promising Prognostic Biomarker in Esophageal Squamous Cell Carcinoma: A Systematic Review and Meta-analysis.
Otsuka R, Sakata H, Murakami K, Kano M, Endo S, Toyozumi T, Matsumoto Y, Suito H, Takahashi M, Sekino N, Hirasawa S, Kinoshita K, Sasaki T, Matsubara H. Otsuka R, et al. Among authors: toyozumi t. Cancer Diagn Progn. 2022 Mar 3;2(2):126-133. doi: 10.21873/cdp.10086. eCollection 2022 Mar-Apr. Cancer Diagn Progn. 2022. PMID: 35399170 Free PMC article. Review.
Serum Versus Tissue SIRT1 as Potentially Valuable Biomarkers in Gastric Cancer.
Otsuka R, Morishita H, Iida K, Hayano K, Murakami K, Endo S, Toyozumi T, Matsumoto Y, Kurata Y, Kinoshita K, Sasaki T, Iida S, Nishioka Y, Matsubara H. Otsuka R, et al. Among authors: toyozumi t. Anticancer Res. 2023 Apr;43(4):1485-1491. doi: 10.21873/anticanres.16297. Anticancer Res. 2023. PMID: 36974791
Hypoxia‑regulated exosomal miR‑185 inhibits esophageal squamous cell carcinoma progression and predicts prognosis.
Maiyulan A, Matsumoto Y, Wang H, Murakami K, Toyozumi T, Otsuka R, Shiraishi T, Kinoshita K, Hu J, Iida S, Morishita H, Makiyama T, Nishioka Y, Kano M, Matsubara H. Maiyulan A, et al. Among authors: toyozumi t. Oncol Lett. 2024 May 22;28(1):334. doi: 10.3892/ol.2024.14467. eCollection 2024 Jul. Oncol Lett. 2024. PMID: 38827568 Free PMC article.
SIRT1 Promotes Chemoradiotherapy Resistance in Esophageal Squamous Cell Carcinoma.
Morishita H, Otsuka R, Murakami K, Endo S, Toyozumi T, Matsumoto Y, Shiraishi T, Iida S, Makiyama T, Nishioka Y, Hu J, Maiyulan A, Matsubara H. Morishita H, et al. Among authors: toyozumi t. Oncology. 2024;102(11):960-968. doi: 10.1159/000540247. Epub 2024 Jul 22. Oncology. 2024. PMID: 38972308
65 results